IMPACT OF SUBSIDIZED ARTEMETHER-LUMEFANTRINE (AL) IN THE RETAIL SECTOR ON COVERAGE OF PROMPT EFFECTIVE TREATMENT OF CHILDREN UNDER FIVE IN KENYA: A CLUSTER RANDOMIZED CONTROLLED TRIAL

IMPACT OF SUBSIDIZED ARTEMETHER-LUMEFANTRINE (AL) IN THE RETAIL SECTOR ON COVERAGE OF PROMPT EFFECTIVE TREATMENT OF CHILDREN UNDER FIVE IN KENYA: A CLUSTER RANDOMIZED CONTROLLED TRIAL

Bibliographic Details
Main Authors:	Kangwana, B, Osano, S, Noor, A, Alegana, V, Nyandigisi, A, Pandit, J, Andrews, M, Bunyi, M, Fegan, G, Brooker, S, Snow, R, Goodman, C
Format:	Conference item
Published:	2010

Similar Items

The impact of retail-sector delivery of artemether-lumefantrine on malaria treatment of children under five in Kenya: a cluster randomized controlled trial.
by: Kangwana, B, et al.
Published: (2011)

Understanding the impact of subsidizing artemisinin-based combination therapies (ACTs) in the retail sector--results from focus group discussions in rural Kenya
by: Kedenge, S, et al.
Published: (2013)

The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya.
by: Sudoi, R, et al.
Published: (2012)

The use of artemether-lumefantrine by febrile children following national implementation of a revised drug policy in Kenya.
by: Gitonga, C, et al.
Published: (2008)

The effect of an anti-malarial subsidy programme on the quality of service provision of artemisinin-based combination therapy in Kenya: a cluster-randomized, controlled trial.
by: Kangwana, B, et al.
Published: (2013)

Translation of artemether-lumefantrine treatment policy into paediatric clinical practice: an early experience from Kenya.
by: Zurovac, D, et al.
Published: (2008)

Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine
by: White, N, et al.
Published: (1999)

Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.
by: White, N, et al.
Published: (1999)

Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine.
by: Ali, S, et al.
Published: (2010)

Introduction of malaria rapid diagnostic tests, new guidelines, and artemether-lumefantrine in Kenya: A cluster randomized trial
by: Skarbinski, J, et al.
Published: (2007)

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia
by: Sipilanyambe, N, et al.
Published: (2008)

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia.
by: Sipilanyambe, N, et al.
Published: (2008)

Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine.
by: Wasunna, B, et al.
Published: (2008)

Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine
by: Wasunna, B, et al.
Published: (2008)

Changing malaria intervention coverage, transmission and hospitalization in Kenya.
by: Okiro, E, et al.
Published: (2010)

The impact of a community awareness strategy on caregiver treatment seeking behaviour and use of artemether-lumefantrine for febrile children in rural Kenya
by: Wasunna, B, et al.
Published: (2015)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda.
by: Zurovac, D, et al.
Published: (2008)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda
by: Zurovac, D, et al.
Published: (2008)

No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine.
by: van Vugt, M, et al.
Published: (1999)

Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria.
by: van Vugt, M, et al.
Published: (2000)

Effect of malaria rapid diagnostic tests on the management of uncomplicated malaria with artemether-lumefantrine in Kenya: a cluster randomized trial.
by: Skarbinski, J, et al.
Published: (2009)

Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
by: Tarning, J, et al.
Published: (2009)

Population pharmacokinetics and pharmacodynamics of lumefantrine in young Ugandan children treated with artemether-lumefantrine for uncomplicated malaria
by: Tchaparian, E, et al.
Published: (2016)

Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda.
by: Mwesigwa, J, et al.
Published: (2010)

Drug interactions between dolutegravir and artemether-lumefantrine or artesunate-amodiaquine
by: Walimbwa, S, et al.
Published: (2018)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
by: Mcgready, R, et al.
Published: (2006)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
by: McGready, R, et al.
Published: (2009)

Artemether-lumefantrine coadministration with antiretrovirals; population pharmacokinetics and dosing implications.
by: Hoglund, R, et al.
Published: (2014)

Severe acute malnutrition results in lower lumefantrine exposure in children treated with artemether‐lumefantrine for uncomplicated malaria
by: Chotsiri, P, et al.
Published: (2019)

Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
by: Peto, TJ, et al.
Published: (2022)

Predicting the unmet need for biologically targeted coverage of insecticide-treated nets in Kenya.
by: Noor, A, et al.
Published: (2010)

Antimalarial resistance unlikely to explain U.K. artemether-lumefantrine failures
by: van der Pluijm, R, et al.
Published: (2017)

Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia.
by: Denis, M, et al.
Published: (2006)

Genomic characterization of recrudescent plasmodium malariae after treatment with artemether/lumefantrine
by: Rutledge, G, et al.
Published: (2017)

A case-control auditory evaluation of patients treated with artemether-lumefantrine.
by: Hutagalung, R, et al.
Published: (2006)

Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria
by: Tarning, J, et al.
Published: (2022)

Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study.
by: Zurovac, D, et al.
Published: (2007)

Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
by: Zurovac, D, et al.
Published: (2007)

Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial
by: Kamya, MR, et al.
Published: (2007)

Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study.
by: Zurovac, D, et al.
Published: (2005)